LifeScience PLUS

BloodSTOP® and BloodSTOP® iX are biocompatible, non-irritating, woven matrices of fibers made from natural plant compounds. They adhere to a wound, initiate blood coagulation, stop bleeding, and form a protective layer to create an optimal environment for wound healing. Their water solubility allows for removal by rinsing, without disruption of a clotted surface.

These products are covered by U.S. Patent No. 7,262,181.

Next Generation Wound Care Products for the World

 

Who we are

LifeScience PLUS is a medical device company committed to developing and marketing innovative next-generation wound care technology. Through our line of BloodSTOP® wound care products, we have created a unique and revolutionary hemostatic matrix. BloodSTOP® is a plant-derived, hydrophilic material that, when properly applied, will actively aid blood coagulation and create a physical barrier and an environment for improved wound healing.

The BloodSTOP product family is at the forefront of a new generation of wound care products for medical and dental industries that are not only more practical to administer but also more effective and palliative for the patient.

Envisioning Progress

LifeScience PLUS founding members recognized early on the need for wound care products that could address the disadvantages of traditional dressings and adhesive bandages. Convenient, cost-effective and proven for a range of applications, the Company’s flagship BloodSTOP and BloodSTOP iX products are FDA cleared for external usage.  BloodSTOP and BloodSTOP iX are CE certified for external use, and BloodSTOP iX for internal surgical use in Europe and other OUS markets.  LifeScience PLUS has identified and is actively exploring future indications for the medical professional marketplace based on clinical data and feedback from the medical community.

 

The Latest News

LSP at EMS World Expo

 
July 23, 2014
LifeScience PLUS is pleased to announce that it will be exhibiting BloodSTOP products at the EMS World Expo in Nashville, TN, November 9-13, 2014

LSP Supports US Armed Services Charity Run

LifeSciencePLUS PRESS RELEASE

July 18, 2014

LifeScience PLUS is honored to be the Run Finale Venue Sponsor for Always Brothers Foundation's 100 Miles Memorial Run on July 26th in Seattle. 

BloodSTOP now approved in EU for use with blood thinning medications!

LifeSciencePLUS, Inc., is pleased to announce the recertification of its Class IIb CE Mark Certification for the BloodSTOP® line of topical hemostats.  The recertification has been extended to include bleeding control for people on anti-coagulant medications.

Efficacy Studies of BloodSTOP® iX as compared with Surgicel® and Gelfoam®

UCSF preclinical study done in conjunction with University Hospital Pellegrin in France shows BloodSTOP iX® controls bleeding up to three times faster than Gelfoam® or Surgicel®.

BloodSTOP® and BloodSTOP® iX Effective at Controlling Bleeding on Test Subjects Receiving Coumadin, Aspirin & Plavix, and Heparin

A preclinical study performed in accordance with GLP guidelines, tested BloodSTOP and BloodSTOP iX on a group of animals receiving anticoagulant drugs against a control subject that received none.  Tests showed hemostasis was achieved in the anticoagulant group in a time that was statistically significant and comparable to that of the control subject.


Read More News